New Hampshire Trust’s Pfizer PFE Stock Holding History

New Hampshire Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399K	Sell	16,564 -760	-4%	-$19.9K	0.08%	132
2026 Q1	$486K	Hold	17,324	–	–	0.1%	117
2025 Q4	$431K	Hold	17,324	–	–	0.08%	124
2025 Q3	$441K	Sell	17,324 -1,009	-6%	-$24.9K	0.09%	129
2025 Q2	$444K	Hold	18,333	–	–	0.09%	122
2025 Q1	$465K	Sell	18,333 -1,247	-6%	-$32.6K	0.11%	113
2024 Q4	$519K	Sell	19,580 -8,836	-31%	-$240K	0.11%	112
2024 Q3	$822K	Sell	28,416 -6,582	-19%	-$192K	0.18%	88
2024 Q2	$979K	Sell	34,998 -2,676	-7%	-$73.7K	0.22%	80
2024 Q1	$1.05M	Sell	37,674 -9,821	-21%	-$273K	0.24%	79
2023 Q4	$1.37M	Sell	47,495 -4,840	-9%	-$146K	0.33%	72
2023 Q3	$1.74M	Sell	52,335 -380	-0.7%	-$13.4K	0.47%	63
2023 Q2	$1.93M	Sell	52,715 -742	-1%	-$28.9K	0.5%	60
2023 Q1	$2.18M	Sell	53,457 -1,403	-3%	-$60.6K	0.59%	55
2022 Q4	$2.81M	Buy	+54,860	New	+$2.63M	0.74%	39

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New Hampshire Trust's PFE Position: Q2 2026 in Review

New Hampshire Trust reduced its Pfizer (PFE) stake by 4.4% in Q2 2026, selling an estimated $19.9K and leaving 16,564 shares worth $399K. The position accounts for 0.08% of the portfolio, ranked #132.

New Hampshire Trust first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.81M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

New Hampshire Trust held 16,564 shares of Pfizer worth $399K as of Q2 2026.
New Hampshire Trust sold 760 Pfizer shares in Q2 2026, an estimated $19.9K.
Pfizer made up 0.08% of New Hampshire Trust's portfolio in Q2 2026, its #132 holding.
New Hampshire Trust first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
New Hampshire Trust's Pfizer position peaked at $2.81M in Q4 2022.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.